Page 83 - Puneet Wadhwa/undefined

Patanjali Ayurved targets 250% revenue growth in FY16: Edelweiss

Earlier in August 2015, global brokerage and research house CLSA pegged Patanjali Ayurved to be the most diversified FMCG player in India and bigger than listed players like Jyothy Labs and Emami

Realty, consumer durables, pharma stocks shine in Sensex's over 2,000 points rally

BSE realty index, largest gainer among the sectoral indices, surged 17% in the past month

4 reasons why Jefferies has downgraded Maruti Suzuki

Govindarajan Chellappa and Apurva Kumar, analysts with Jefferies who have co-authored the report believe that investors don't seem to be looking beyond its rather bright near-term prospects

Time for relook at rate-sensitives

Experts feel select companies in banking, automobiles, financial services & real estate will gain from lower interest rates

RBI rate cut: What next for the markets?

Analysts say that though the quantum of rate cut did surprise the markets, the euphoria could be short-lived. The road ahead will be dictated more by global events, they suggest

Markets on Thursday: Range-bound movement likely ahead of F&O expiry

Jubilant FoodWorks, JSW Steel, M&M Financial, RCom, Aurobindo Pharma, UBL, IDBI, TCS and GAIL top in stock-wise rollover, analysts say

CNX Nifty to be renamed Nifty 50

CNX 100, CNX 200, CNX 500, CNX Midcap, CNX Small-cap indices will also be renamed effective 09 November, 2015

Amtek Auto tumbles 20% on reports of missing Rs 800 crore bond payment deadline

The stock opened at Rs 46.75 on the BSE and touched an intra-day low of Rs 41.55 before recovering to Rs 46.6 levels around 12 noon

Nifty can hit 10,000 levels by December-end: Andrew Holland

Interview with Chief executive officer- investment advisory, Ambit Capital

Sensex soars 500 points; will the rally sustain?

Though analysts maintain that the rally could have more steam left, this still remains 'sell on a rise market' for them

US Fed outcome: What next for the markets?

Though US Fed's decision augurs well, analysts say, RBI's stance on rates, corporate results and outcome of Bihar elections are the next triggers for a market rally

Whatever Fed does, I don't see people selling off India: Motilal Oswal

Interview with chairman and managing director, Motilal Oswal Financial Services

91 stocks outrun markets after June quarter results

Post the US Fed meet outcome, analysts say, it is the fundamentals of companies that will drive stock performance. The ones on a stable footing will rise faster

How will the Indian market fare after the US Fed meet?

A delay in US Fed action to December, analysts say, could stall flows into India

India can get annual FII flows to the tune of $15-20 bn: Vikas Khemani

Interview with President & CEO, Edelweiss Securities

Sensex gains 700 points in two days; will the market rally last?

It has gained 826 pts in 2 days, global markets have also risen but experts doubt if this is sustainable and for how long

Earnings growth: Markets waking up to the reality

In FY15 , brokerages did not cut forecasts to bring it in sync with ground realities, this time they seem to be proactive

CNX Pharma index down for sixth straight day

Jubilant Life, Dishman Pharma, Suven Life, Natco Pharma, JB Chem, Marksans Pharma and Unichem down 4%-10%.

3 reasons why the Sensex plunged 700 points today

Here are three reasons why the global markets, including India lost ground on Tuesday

August sees highest monthly FII outflow ever

August also saw equity markets suffer their worst single-day fall in almost seven years with the S&P BSE Sensex sliding 1,624 points in a single day